Leymus Genomics ApS: Financial statements 2023
CVR: 38106872
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Leymus Genomics ApS (CVR 38106872) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -1,341,461 and a net result of DKK -1,269,016 compared with DKK -1,655,772 the year before. Equity in the 2023 report amounted to DKK -124,553. The company had 1 employee in the financial year.
- Gross Profit
- DKK -1,341,461
- Profit/Loss
- DKK -1,269,016
- Equity
- DKK -124,553
- Total Assets
- DKK 828,452
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -1.3M | -1.3M | -125K | 1 |
| 2022 | - | 333K | -1.7M | 1.1M | 3 |
| 2021 | - | 6.1M | 3M | 3.7M | 4 |
| 2020 | - | 604K | 347K | 638K | 1 |
| 2019 | - | -156K | -370K | 291K | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Leymus Genomics ApS has published its annual report for 2022. Gross profit came to DKK 332,776, and the net result was DKK -1,655,772.
About Leymus Genomics ApS
Leymus Genomics ApS was a Danish company of the type Anpartsselskab based in Herlev, founded in 2016. The company has been dissolved on 28 November 2024. The company was registered under the industry Engroshandel med andre maskiner og andet udstyr. The company was previously named Leymus Scientific Capital ApS. The company has 3 employees (2023). In 2023, the company reported a gross profit of DKK -1,341,461 and a net result of DKK -1,269,016 compared with DKK -1,655,772 the year before. Equity in the 2023 report amounted to DKK -124,553.